Logo image of CUR.CA

CONSOLIDATED URANIUM INC (CUR.CA) Stock Fundamental Analysis

TSX-V:CUR - TSX Venture Exchange - CA21024C1014 - Common Stock - Currency: CAD

1.93  +0.05 (+2.66%)

Fundamental Rating

1

CUR gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 808 industry peers in the Metals & Mining industry. CUR has a bad profitability rating. Also its financial health evaluation is rather negative. CUR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

CUR had negative earnings in the past year.
In the past year CUR has reported a negative cash flow from operations.
CUR had negative earnings in each of the past 5 years.
In the past 5 years CUR always reported negative operating cash flow.
CUR.CA Yearly Net Income VS EBIT VS OCF VS FCFCUR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -20M -40M -60M

1.2 Ratios

CUR's Return On Assets of -410.01% is on the low side compared to the rest of the industry. CUR is outperformed by 93.10% of its industry peers.
CUR's Return On Equity of -563.23% is on the low side compared to the rest of the industry. CUR is outperformed by 83.83% of its industry peers.
Industry RankSector Rank
ROA -410.01%
ROE -563.23%
ROIC N/A
ROA(3y)-106.62%
ROA(5y)-158.47%
ROE(3y)-131.22%
ROE(5y)-182.34%
ROIC(3y)N/A
ROIC(5y)N/A
CUR.CA Yearly ROA, ROE, ROICCUR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -100 -200 -300 -400

1.3 Margins

CUR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CUR.CA Yearly Profit, Operating, Gross MarginsCUR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022

More info and screens

3

2. Health

2.1 Basic Checks

CUR has more shares outstanding than it did 1 year ago.
CUR has a better debt/assets ratio than last year.
CUR.CA Yearly Shares OutstandingCUR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M
CUR.CA Yearly Total Debt VS Total AssetsCUR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

2.2 Solvency

CUR has an Altman-Z score of -2.57. This is a bad value and indicates that CUR is not financially healthy and even has some risk of bankruptcy.
CUR has a worse Altman-Z score (-2.57) than 69.08% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that CUR is not too dependend on debt financing.
The Debt to Equity ratio of CUR (0.03) is worse than 63.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -2.57
ROIC/WACCN/A
WACCN/A
CUR.CA Yearly LT Debt VS Equity VS FCFCUR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M -20M

2.3 Liquidity

CUR has a Current Ratio of 3.60. This indicates that CUR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.60, CUR is in line with its industry, outperforming 58.86% of the companies in the same industry.
A Quick Ratio of 3.60 indicates that CUR has no problem at all paying its short term obligations.
The Quick ratio of CUR (3.60) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.6
Quick Ratio 3.6
CUR.CA Yearly Current Assets VS Current LiabilitesCUR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

More info and screens

0

3. Growth

3.1 Past

CUR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.86%, which is quite impressive.
EPS 1Y (TTM)36.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.32%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CUR will show a decrease in Earnings Per Share. The EPS will decrease by -1.49% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-147.2%
EPS Next 2Y-1.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CUR.CA Yearly EPS VS EstimatesCUR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 -0.1 -0.2 -0.3 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CUR. In the last year negative earnings were reported.
Also next year CUR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CUR.CA Price Earnings VS Forward Price EarningsCUR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CUR.CA Per share dataCUR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.49%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CUR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CONSOLIDATED URANIUM INC

TSX-V:CUR (12/8/2023, 7:00:00 PM)

1.93

+0.05 (+2.66%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap199.71M
Analysts84
Price Target5.1 (164.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)25%
PT rev (3m)25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 14.12
P/tB 14.12
EV/EBITDA N/A
EPS(TTM)-0.82
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -410.01%
ROE -563.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-106.62%
ROA(5y)-158.47%
ROE(3y)-131.22%
ROE(5y)-182.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 230.53%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.6
Quick Ratio 3.6
Altman-Z -2.57
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.32%
EPS Next Y-147.2%
EPS Next 2Y-1.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-86.75%
OCF growth 3YN/A
OCF growth 5YN/A